Improving the way we manage glaucoma patients - Ariel Cao

Ariel Cao is the president/CEO and co-founder of Injectsense. We talked about the current challenges in the management of patients with glaucoma, still one of the major causes of blindness worldwide. Cao and his team developed an implantable intraocular device that can continuously monitor intraocular pressure. By providing accurate, clinically actionable information, physicians will be able to individualize therapeutic interventions for each patient, properly assess the effectiveness of glaucoma therapy, and ultimately avoid blindness.
For more information on the guest, check out our website:
Listen on Spotify: spoti.fi/31XqFak
Listen on Google Podcasts: bit.ly/30qrtUr
Listen on Apple Podcasts: apple.co/3ouneQh
Follow us on Social Media:
Facebook: / broadeyepodcast
LinkedIn: / broa. .
Twitter: / broadeyepodcast